Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Marinus Pharma CS (MRNS)
Marinus Pharma CS (MRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 404,880
  • Shares Outstanding, K 50,610
  • Annual Sales, $ 25,480 K
  • Annual Income, $ -19,820 K
  • 60-Month Beta 1.35
  • Price/Sales 15.56
  • Price/Cash Flow N/A
  • Price/Book 6.30
Trade MRNS with:

Options Overview Details

View History
  • Implied Volatility 73.74% ( +2.03%)
  • Historical Volatility 87.54%
  • IV Percentile 44%
  • IV Rank 15.08%
  • IV High 209.58% on 01/03/23
  • IV Low 49.61% on 09/20/23
  • Put/Call Vol Ratio 0.96
  • Today's Volume 147
  • Volume Avg (30-Day) 145
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 21,664
  • Open Int (30-Day) 20,747

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate -0.67
  • Number of Estimates 6
  • High Estimate -0.63
  • Low Estimate -0.71
  • Prior Year -0.35
  • Growth Rate Est. (year over year) -91.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.79 +42.31%
on 09/18/23
8.27 -0.36%
on 09/28/23
+0.90 (+12.26%)
since 08/28/23
3-Month
5.79 +42.31%
on 09/18/23
11.13 -25.97%
on 06/29/23
-2.73 (-24.85%)
since 06/28/23
52-Week
3.46 +137.81%
on 12/27/22
11.15 -26.10%
on 06/13/23
+1.25 (+17.97%)
since 09/28/22

Most Recent Stories

More News
Marinus Pharmaceuticals: Q2 Earnings Snapshot

Marinus Pharmaceuticals: Q2 Earnings Snapshot

MRNS : 8.24 (+3.00%)
Marinus Pharmaceuticals (MRNS) Reports Q1 Loss, Tops Revenue Estimates

Marinus Pharmaceuticals (MRNS) delivered earnings and revenue surprises of 12.99% and 94.86%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

MRNS : 8.24 (+3.00%)
VVOS : 0.1823 (-4.10%)
Marinus Pharmaceuticals: Q1 Earnings Snapshot

Marinus Pharmaceuticals: Q1 Earnings Snapshot

MRNS : 8.24 (+3.00%)
4D Molecular Therapeutics, Inc. (FDMT) Reports Q1 Loss, Lags Revenue Estimates

4D Molecular Therapeutics, Inc. (FDMT) delivered earnings and revenue surprises of 0% and 79.49%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

FDMT : 12.64 (-2.92%)
MRNS : 8.24 (+3.00%)
Earnings Preview: Marinus Pharmaceuticals (MRNS) Q1 Earnings Expected to Decline

Marinus Pharmaceuticals (MRNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MRNS : 8.24 (+3.00%)
NKTR : 0.6100 (+1.36%)
Marinus Pharmaceuticals to Present at Upcoming Investor Conferences

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that management will present...

MRNS : 8.24 (+3.00%)
Marinus Pharmaceuticals to Provide Business Update and Report First Quarter 2023 Financial Results on May 11, 2023

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that it plans to release financial...

MRNS : 8.24 (+3.00%)
Marinus Pharmaceuticals Appoints Marvin H. Johnson, Jr. to its Board of Directors

Marinus Pharmaceuticals , Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the appointment of Marvin H....

MRNS : 8.24 (+3.00%)
Marinus Pharmaceuticals (MRNS) Stock Jumps 8.4%: Will It Continue to Soar?

Marinus Pharmaceuticals (MRNS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the...

MRNS : 8.24 (+3.00%)
PCRX : 30.85 (-0.61%)
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Marinus Pharmaceuticals, Inc . (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the grant of inducement awards...

MRNS : 8.24 (+3.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Marinus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It is focused on developing and commercializing therapeutics for the treatment of epilepsy and other targeted neurological, behavioral and psychiatric disorders. The Company offers Ganaxolone which has completed Phase II clinical...

See More

Key Turning Points

3rd Resistance Point 9.09
2nd Resistance Point 8.68
1st Resistance Point 8.46
Last Price 8.24
1st Support Level 7.83
2nd Support Level 7.42
3rd Support Level 7.20

See More

52-Week High 11.15
Last Price 8.24
Fibonacci 61.8% 8.21
Fibonacci 50% 7.31
Fibonacci 38.2% 6.40
52-Week Low 3.46

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar